CIMAP2 and laminopathy: Importantly, dysregulation of LEM-domain-mediated signaling is increasingly recognized as a key contributor to nuclear envelope-associated diseases, particularly muscle-related disorders such as Emery–Dreifuss muscular dystrophy and other laminopathies.